Skip to main content
Glama

Drug Indications

drug_indications
Read-onlyIdempotent

Retrieve approved drug indication records from ChEMBL filtered by molecule_chembl_id and/or MeSH disease ID; returns disease names, efo_id cross-references, and max clinical trial phase.

Input Schema

NameRequiredDescriptionDefault
limitNo
mesh_idNo
molecule_chembl_idNo

Output Schema

NameRequiredDescriptionDefault
page_metaNo
drug_indicationsNo

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

A4/5.0
Behavior3/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false. The description adds some behavioral context by specifying 'approved' indications and 'max clinical trial phase', but it doesn't disclose additional traits like authentication needs or rate limits. This is acceptable but not rich.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single, well-structured sentence that front-loads the main purpose and lists key return fields without unnecessary wording. Every part adds value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With an output schema present, the description does not need to explain return values in depth. It covers the main filters and return fields, but misses the limit parameter and does not mention open-world behavior beyond annotations. Overall, it is complete enough for a read-only query tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema descriptions are 0% covered. The description explains molecule_chembl_id and mesh_id ('MeSH disease ID'), which is helpful, but it omits the 'limit' parameter entirely. Since description must compensate for lack of schema descriptions, partial coverage earns a mid-range score.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states a specific action ('Retrieve approved drug indication records from ChEMBL'), identifies the resource, and specifies filters and return fields. This distinguishes it from sibling tools like molecule or target, which focus on other entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides clear context on when to use the tool (when needing drug indication data filtered by molecule or MeSH ID) and what it returns. However, it does not explicitly name alternatives or exclusions, so it stops short of a perfect 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.